Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference25 articles.
1. Beatson G: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases.Lancet 2: 104–107, 1896.
2. Buzdar A, Jonat W, Howell A, Jones S, Blomqvist C, Vogel C, Eirmann W, Wolter J, Azab M, Webster A, and Plourde P: Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in post-menopausal women with advanced breast cancer: results of overview analysis of two phase El trials.J Clin Oncol 14: 2000–2011, 1996.
3. Buzdar A, Jonat W, Howell A, Yin H, and Lee D: Significant improved survival with Arimadex (anastrazole) versus megestrol acetate in postmenopausal advanced breast cancer: updated results of two randomized trials.Proc Am Soc Clin Oncol 16: 156a, 1997.
4. Kaufmann M, Bajetta E, Dirix L,et al: Exemestane is superior to megestrol acetate after tamoxifen failure in post-menopausal women with advanced breast cancer: results of a phase III randomised double-blind trial. The Exemestane Study Group.J Clin Oncol 18: 1399–1411, 2000.
5. Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffman W, Michel J, Hatschek T, Tjabbes T, Chaudri H, Hornberger U, and Tramet P: Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.J Clin Oncol 16: 453–461, 1998.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献